Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

QSI

Quantum-Si Incorporated

Sep 16 • 02:39PM ET

0.9410

Dollar change +0.0178
Percentage change 1.93	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: ARKG VTI IWM VXF IWN VTWO IWC VTWV RSSL IWV

Index	RUT	P/E	-	EPS (ttm)	-0.63	Insider Own	32.07%	Shs Outstand	121.83M	Perf Week	-0.94%
Market Cap	133.96M	Forward P/E	-	EPS next Y	-0.79	Insider Trans	0.66%	Shs Float	96.71M	Perf Month	-7.75%
Income	-89.35M	PEG	-	EPS next Q	-0.20	Inst Own	31.45%	Short Float	6.20%	Perf Quarter	-31.31%
Sales	1.70M	P/S	78.80	EPS this Y	1.47%	Inst Trans	-1.76%	Short Ratio	7.37	Perf Half Y	-45.61%
Book/sh	1.64	P/B	0.57	EPS next Y	-17.91%	ROA	-29.89%	Short Interest	5.99M	Perf Year	-58.73%
Cash/sh	1.53	P/C	0.61	EPS next 5Y	-	ROE	-32.58%	52W Range	0.73 - 2.43	Perf YTD	-53.18%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-38.30%	52W High	-61.28%	Beta	2.90
Dividend TTM	-	Quick Ratio	20.13	Sales past 5Y	0.00%	Gross Margin	-223.38%	52W Low	28.55%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	20.57	EPS Y/Y TTM	22.49%	Oper. Margin	-5999.65%	RSI (14)	48.91	Volatility	7.24% 8.15%
Employees	165	Debt/Eq	0.01	Sales Y/Y TTM	270.81%	Profit Margin	-5249.65%	Recom	2.00	Target Price	2.75
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	9.96%	Payout	-	Rel Volume	0.30	Prev Close	0.92
Sales Surprise	-11.65%	EPS Surprise	13.51%	Sales Q/Q	203.41%	Earnings	Aug 07 AMC	Avg Volume	812.82K	Price	0.94
SMA20	-0.82%	SMA50	-3.82%	SMA200	-37.15%	Trades		Volume	195,247	Change	1.93%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-08-23	Initiated	H.C. Wainwright	Buy	$3
Sep-25-23	Downgrade	Canaccord Genuity	Buy → Hold	$3.50 → $2
Oct-20-21	Initiated	Canaccord Genuity	Buy	$13

Sep-04-24 06:00AM	Liberate Bio Integrates Quantum-Si's Next-Generation Protein Sequencing Platform to Enhance Gene Therapy Development (Business Wire)
Aug-27-24 06:01PM	CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider (Business Wire)
04:30PM	Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider (Business Wire)
Aug-26-24 06:00AM	Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire) -5.94%
Aug-07-24 04:02PM	Quantum-Si Reports Second Quarter 2024 Financial Results (Business Wire) -5.91%
04:05PM	Loading…
Jul-30-24 04:05PM	Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-17-24 04:05PM	Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire) -6.03%
Jul-09-24 03:56PM	3 Super-Cheap Penny Stocks for the Ultimate Speculator (InvestorPlace)
Jun-10-24 09:00AM	Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata (Business Wire)
May-31-24 08:00AM	Quantum-Si Announces Presentations at ASMS and ESHG (Business Wire)
May-30-24 04:05PM	Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors (Business Wire)
May-09-24 04:01PM	Quantum-Si Reports First Quarter 2024 Financial Results (Business Wire) -7.10%
Apr-30-24 08:30AM	Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time (Business Wire)
Apr-18-24 04:05PM	Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024 (Business Wire)
Mar-21-24 04:05PM	Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors (Business Wire) -5.79%
12:01PM	Loading…
Mar-07-24 12:01PM	Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing on Platinum at US HUPO Conference (Business Wire) +29.81%
Feb-29-24 04:05PM	Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire) +10.78%
Feb-27-24 08:30AM	Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar (Business Wire) +5.36%
Feb-09-24 08:00AM	Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 (Business Wire) +6.94%
Feb-05-24 08:00AM	Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing Platform (Business Wire)
Jan-18-24 08:30AM	Quantum-Si Introduces Worlds First Next-Generation Protein Sequencer in Japan with Addition of New Distributor (Business Wire)
Dec-12-23 08:30AM	Quantum-Si Expands Global Reach with Addition of New Distributor (Business Wire)
Nov-15-23 08:30AM	Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum Grows (Business Wire)
Nov-11-23 09:18AM	Quantum-Si incorporated (NASDAQ:QSI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:05PM	Quantum-Si Reports Third Quarter 2023 Financial Results (Business Wire) +7.26% +6.77%
Nov-08-23 08:15AM	Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards (Business Wire) -6.06%
Nov-01-23 08:30AM	Quantum-Si to Participate at Two Upcoming Investor Conferences (Business Wire)
Oct-31-23 08:00AM	Quantum-Si Presents its Vision to Transform Genomics and Proteomics Research at ASHG 2023 (Business Wire)
Oct-17-23 08:30AM	Quantum-Si to Report Third Quarter 2023 Financial Results on November 9, 2023 (Business Wire)
Oct-05-23 06:36PM	CORRECTING AND REPLACING Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization (Business Wire)
08:00AM	Loading…
08:00AM	Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization (Business Wire)
Oct-03-23 08:00AM	Quantum-Si to Present at The Festival of Genomics & Biodata 2023 in Boston, Massachusetts (Business Wire)
Sep-21-23 08:00AM	Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors (Business Wire)
Aug-22-23 07:05AM	Quantum-Sis Platinum Next-Generation Protein Sequencing Instrument Wins Honorable Mention in Fast Companys 2023 Innovation by Design Awards (Business Wire)
Aug-16-23 04:00PM	Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-14-23 06:02PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -9.73%
Aug-07-23 08:00AM	Quantum-Si Reports Second Quarter 2023 Financial Results (Business Wire) -32.15%
Jul-26-23 08:00AM	Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference (Business Wire)
Jul-18-23 04:00PM	Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023 (Business Wire) +9.57%
Jun-21-23 08:00AM	Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations (Business Wire)
Jun-07-23 08:00AM	Quantum-Si Debuts New Headquarters in Branford, Connecticut (Business Wire)
May-25-23 08:00AM	Quantum-Si to Participate in the Jefferies Healthcare Conference (Business Wire) -5.99%
May-22-23 08:00AM	Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors (Business Wire) +15.13%
May-15-23 08:00AM	Scott Mendel Elected to Quantum-Si Board of Directors (Business Wire)
May-11-23 04:00PM	Quantum-Si Reports First Quarter 2023 Financial Results (Business Wire) -5.52% -8.44%
May-02-23 08:00AM	Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer (Business Wire)
Apr-24-23 08:00AM	Quantum-Si Bolsters Executive Leadership Team with Four Key Appointments (Business Wire)
Apr-20-23 08:00AM	Quantum-Si to Report First Quarter 2023 Financial Results on May 11, 2023 (Business Wire)
Apr-14-23 08:00AM	Quantum-Si To Present Poster on Single-Molecule Method for Detection of Arginine Post-Translational Modifications at the AACR Annual Meeting 2023 (Business Wire)
Mar-24-23 08:00AM	Quantum-Si to Participate in B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference (Business Wire)
Mar-06-23 08:00AM	Quantum-Si Reports Fourth Quarter and Fiscal Year 2022 Financial Results (Business Wire) -12.96%
Feb-17-23 08:00AM	Quantum-Si to Participate in the 43rd Annual Cowen Health Care Conference (Business Wire)
Feb-13-23 04:00PM	Quantum-Si to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 (Business Wire)
Jan-09-23 08:00AM	Quantum-Si Begins Commercial Shipments of the PlatinumTM Protein Sequencing System and Provides Business Updates at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire) +8.72%
08:00AM	Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum Next-Generation Protein Sequence Platform Output (Business Wire)
08:00AM	Quantum-Si and Aviva Systems Biology Partner to Co-Develop Sample Preparation Kits for Protein Sequencing (Business Wire)
Dec-22-22 04:05PM	Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-20-22 08:00AM	Quantum-Si Announces Commercial Availability of PlatinumTM, the Worlds First Next-Generation Single-Molecule Protein Sequencing Platform (Business Wire)
Dec-08-22 08:00AM	Quantum-Si Joins Human Proteome Organization (HUPO) Industrial Advisory Board (Business Wire)
Nov-07-22 04:05PM	Quantum-Si Reports Third Quarter 2022 Financial Results (Business Wire)
Nov-03-22 04:00PM	Quantum-Si to Participate in the 16th Annual Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) -11.15%
Oct-17-22 04:05PM	Quantum-Si to Report Third Quarter 2022 Financial Results on November 7, 2022 (Business Wire) +6.11%
Oct-13-22 02:00PM	Quantum-Sis Next-Generation Single-Molecule Protein Sequencing Technology Published in Science, Signaling New Era of Life Science and Biomedical Research (Business Wire)
Oct-04-22 08:00AM	Quantum-Si Appoints Jeff Hawkins as Chief Executive Officer (Business Wire) +18.48%
Aug-26-22 08:00AM	Quantum-Si to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference (Business Wire) -6.40%
Aug-08-22 04:02PM	Quantum-Si Reports Second Quarter 2022 Financial Results (Business Wire) -9.34%
Jul-29-22 08:30AM	Quantum-Si to Participate at Two Upcoming Investor Conferences (Business Wire)
Jul-18-22 04:42PM	Quantum-Si to Report Second Quarter 2022 Financial Results on August 8, 2022 (Business Wire) +7.91%
Jun-22-22 08:45AM	Quantum-Si Set to Join the Russell 2000® Index (Business Wire) +6.83%
Jun-16-22 04:30PM	Quantum-Si Appoints Vikram Bajaj, Ph.D., to Board of Directors (Business Wire) -10.71%
Jun-01-22 08:45AM	Quantum-Si Highlights Technology Advancements at the VIB Next-Generation Protein Analysis and Detection Conference (Business Wire)
May-25-22 08:00AM	Quantum-Si to Present at the 2022 Jefferies Healthcare Conference (Business Wire)
May-17-22 11:00AM	Quantum-Si to Present Research and Development Updates at the VIB Next-Generation Protein Analysis and Detection Conference (Business Wire) +8.09%
May-10-22 08:00AM	Quantum-Si to Present at the 2022 UBS Global Healthcare Conference (Business Wire)
May-09-22 04:05PM	Quantum-Si Reports First Quarter 2022 Financial Results (Business Wire) -11.87%
04:01PM	Quantum-Si Appoints Patrick Schneider as President and Chief Operating Officer (Business Wire)
Apr-18-22 04:13PM	Quantum-Si to Report First Quarter 2022 Financial Results on May 9, 2022 (Business Wire)
Mar-28-22 04:05PM	Quantum-Si to Present at the B. Riley Securities Disruptive Biotech Enabling Technologies Virtual Mini Conference (Business Wire) +13.91%
Mar-14-22 12:39PM	What You Need To Know About Quantum-Si incorporated's (NASDAQ:QSI) Investor Composition (Simply Wall St.) -5.85%
Feb-28-22 04:05PM	Quantum-Si Reports Fourth Quarter and Fiscal Year 2021 Financial Results (Business Wire) -5.88% +13.46%
Feb-18-22 09:21AM	Quantum-Si to Present at the 42nd Annual Cowen Health Care Conference (Business Wire) +11.65%
Feb-14-22 04:05PM	Quantum-Si Announces Dr. Jonathan Rothberg as Interim CEO (Business Wire) -6.24%
Feb-07-22 04:05PM	Quantum-Si to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022 (Business Wire)
Jan-10-22 04:10PM	Quantum-Si Provides Business Updates at the 40th Annual J.P. Morgan Healthcare Conference (Business Wire) -9.15% +7.51%
Jan-04-22 08:00AM	Quantum-Si Signs Lease for New Headquarters in New Haven (Business Wire) -6.57%
Dec-21-21 08:00AM	Quantum-Si to Present at the 40th Annual J.P. Morgan Healthcare Conference (Business Wire) +22.91%
Dec-14-21 09:25AM	Quantum-Si Added to the Nasdaq Biotechnology Index (Business Wire)
Dec-02-21 10:15AM	3D Systems Names Claudia Napal Drayton to Board of Directors (GlobeNewswire)
Nov-10-21 04:05PM	Quantum-Si Reports Third Quarter 2021 Financial Results (Business Wire)
Nov-09-21 08:00AM	Quantum-Si Acquires Majelac Technologies to Strengthen Chip Supply Chain (Business Wire)
Nov-04-21 04:05PM	Quantum-Si to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum (Business Wire)
Oct-19-21 04:15PM	Quantum-Si Announces Expansion of Early Access Program for the Platinum Single Molecule Protein Sequencing Platform (Business Wire)
Sep-21-21 04:15PM	Quantum-Si Incorporated to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference (Business Wire) +8.03%
Sep-13-21 11:26AM	What Type Of Shareholders Make Up Quantum-Si incorporated's (NASDAQ:QSI) Share Registry? (Simply Wall St.)
Aug-16-21 04:05PM	Quantum-Si Reports Second Quarter 2021 Financial Results (Business Wire)
Aug-11-21 07:00AM	Quantum-Si to Report Second Quarter 2021 Financial Results on August 16, 2021 (Business Wire) -5.78%
Jul-27-21 08:30AM	Quantum-Si to Report Second Quarter 2021 Financial Results on August 12, 2021 (Business Wire) -8.78%
Jun-24-21 04:05PM	Quantum-Si Signs Lease for Product Development and Operations Facility in San Diego Biotechnology Hub (Business Wire)

Quantum-Si, Inc. engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing, the ability to sequence proteins in a massively parallel fashion. It can be used for the study of nucleic acids. Its platform includes Carbon automated sample preparation instrument, Platinum NGPS instrument, Quantum-Si Cloud software service, and reagent kits and chips for use with its instruments. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hawkins Jeffrey Alan	President & CEO	Aug 09 '24	Buy	0.85	25,000	21,272	1,003,757	Aug 13 06:01 AM
LaPointe Christian	General Counsel & Corp. Secr.	Aug 09 '24	Buy	0.86	25,000	21,610	571,710	Aug 13 06:01 AM
Keyes Jeffry R.	Chief Financial Officer	Aug 09 '24	Buy	0.87	50,000	43,465	446,820	Aug 13 06:01 AM
Kummeth Charles R.	Director	Aug 09 '24	Buy	0.87	138,900	120,926	323,900	Aug 13 06:01 AM
Kummeth Charles R.	Director	Aug 12 '24	Buy	0.89	31,100	27,533	355,000	Aug 13 06:01 AM
Johnston Grace	Chief Commercial Officer	Jun 21 '24	Sale	1.21	4,359	5,262	299,109	Jun 25 07:18 PM
Johnston Grace	Chief Commercial Officer	Jun 24 '24	Sale	1.20	3,169	3,790	295,940	Jun 25 07:18 PM
Hawkins Jeffrey Alan	President & CEO	Mar 14 '24	Buy	1.76	25,000	44,000	25,000	Mar 18 08:21 AM
LaPointe Christian	General Counsel & Corp. Secr.	Mar 15 '24	Buy	1.74	10,000	17,400	257,693	Mar 18 08:07 AM
Keyes Jeffry R.	Chief Financial Officer	Mar 05 '24	Buy	1.61	50,000	80,500	50,000	Mar 06 05:09 PM

Open in Screener

TECH

Bio-Techne Corp

Sep 16 • 02:40PM ET

74.96

Dollar change +0.29
Percentage change 0.39	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VOO VB VBK SPY IVV RSP XLV IBB VHT

Index	S&P 500	P/E	71.76	EPS (ttm)	1.04	Insider Own	1.06%	Shs Outstand	158.22M	Perf Week	3.98%
Market Cap	11.89B	Forward P/E	34.49	EPS next Y	2.17	Insider Trans	-1.18%	Shs Float	156.97M	Perf Month	0.07%
Income	168.08M	PEG	6.38	EPS next Q	0.38	Inst Own	99.39%	Short Float	2.08%	Perf Quarter	-1.20%
Sales	1.16B	P/S	10.26	EPS this Y	4.74%	Inst Trans	1.96%	Short Ratio	3.33	Perf Half Y	3.37%
Book/sh	13.08	P/B	5.73	EPS next Y	17.23%	ROA	6.06%	Short Interest	3.27M	Perf Year	1.25%
Cash/sh	0.96	P/C	77.80	EPS next 5Y	11.25%	ROE	8.33%	52W Range	51.79 - 85.57	Perf YTD	-2.85%
Dividend Est.	0.25 (0.34%)	P/FCF	50.37	EPS past 5Y	11.13%	ROI	6.79%	52W High	-12.40%	Beta	1.27
Dividend TTM	0.32 (0.43%)	Quick Ratio	2.75	Sales past 5Y	10.61%	Gross Margin	66.70%	52W Low	44.74%	ATR (14)	2.21
Dividend Ex-Date	Aug 19, 2024	Current Ratio	3.87	EPS Y/Y TTM	-41.27%	Oper. Margin	21.42%	RSI (14)	54.84	Volatility	2.79% 2.86%
Employees	3100	Debt/Eq	0.20	Sales Y/Y TTM	1.97%	Profit Margin	14.50%	Recom	1.62	Target Price	83.17
Option/Short	Yes / Yes	LT Debt/Eq	0.20	EPS Q/Q	-45.81%	Payout	30.61%	Rel Volume	0.32	Prev Close	74.67
Sales Surprise	-0.13%	EPS Surprise	-0.99%	Sales Q/Q	1.59%	Earnings	Aug 07 BMO	Avg Volume	981.13K	Price	74.96
SMA20	3.07%	SMA50	0.13%	SMA200	2.67%	Trades		Volume	254,938	Change	0.39%

Date	Action	Analyst	Rating Change	Price Target Change
May-22-24	Downgrade	Citigroup	Buy → Neutral	$85
Feb-08-24	Initiated	Scotiabank	Sector Outperform	$80
Feb-02-24	Downgrade	Stifel	Buy → Hold	$65
Dec-07-23	Initiated	UBS	Buy	$80
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$90
Dec-14-22	Initiated	Deutsche Bank	Buy	$100
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$81.25 → $100
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$89
Aug-25-22	Initiated	Credit Suisse	Outperform	$465
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$370
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$600
Mar-08-21	Upgrade	Stephens	Equal-Weight → Overweight	$380 → $425
Feb-23-21	Upgrade	Stifel	Hold → Buy	$435
Jan-25-21	Reiterated	The Benchmark Company	Buy	$320 → $410
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight	$340
Sep-30-20	Initiated	Atlantic Equities	Overweight	$365
Jul-15-20	Downgrade	Stephens	Overweight → Equal-Weight
May-27-20	Downgrade	Stifel	Buy → Hold	$245 → $260
May-14-20	Initiated	The Benchmark Company	Buy	$290

Show Previous Ratings

Today 07:00AM	ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex Manufacture of CAR-T and TCR Therapies (PR Newswire)
Sep-09-24 05:11AM	Heres What Dragged Bio-Techne Corporation (TECH)? (Insider Monkey)
Aug-27-24 07:00AM	ScaleReady announces the inaugural G-Rex Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine (PR Newswire)
Aug-26-24 07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES (PR Newswire)
Aug-23-24 01:04AM	Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) (GuruFocus.com)
02:28PM	Loading…
Aug-08-24 02:28PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Aug-07-24 07:20PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -9.51%
06:30AM	BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Jul-31-24 07:00AM	BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM (PR Newswire)
Jul-29-24 07:00AM	BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO (PR Newswire)
Jul-15-24 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS (PR Newswire)
Jul-12-24 06:58PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Jul-09-24 06:00AM	7 Cheap Biotech Stocks With Major Upside Potential (InvestorPlace)
Jul-02-24 07:06PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
07:00AM	Loading…
May-31-24 07:00AM	BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES (PR Newswire)
May-30-24 07:00AM	BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex SYSTEM AT THE ANNUAL ASMS CONFERENCE (PR Newswire)
May-29-24 07:00AM	ScaleReady Announces $20 Million G-Rex Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing (PR Newswire)
May-23-24 10:26AM	Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1 (Insider Monkey)
07:00AM	BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE (PR Newswire)
May-22-24 07:00AM	BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY (PR Newswire)
May-20-24 01:34PM	7 Biotech Stocks That Could Breathe New Life Into Your Portfolio (InvestorPlace)
May-14-24 04:49AM	Bio-Techne Corporation (TECH) Declined on Weak Q4 Results (Insider Monkey)
May-08-24 07:00AM	BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 (PR Newswire)
May-07-24 07:00AM	BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) (PR Newswire)
May-06-24 05:57AM	Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating (MT Newswires)
May-02-24 11:40AM	Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript (Insider Monkey)
11:31AM	UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating (MT Newswires)
10:49AM	Leerink Partners Adjusts Price Target on Bio-Techne to $95 From $85 (MT Newswires)
10:34AM	Scotiabank Adjusts Price Target on Bio-Techne to $83 From $80 (MT Newswires)
08:17AM	Loading…
08:17AM	RBC Capital Adjusts Price Target on Bio-Techne to $72 From $71, Sector Perform Rating Kept (MT Newswires)
08:00AM	Baird Adjusts Bio-Techne Price Target to $81 From $73 (MT Newswires)
03:11AM	Bio-Techne Corp (TECH) (Q3 2024) Earnings Call Transcript Highlights: Navigating Market ... (GuruFocus.com)
May-01-24 04:54PM	S&P 500 Gains and Losses Today: CVS Falls as Health Care Costs Pressure Profits (Investopedia) +16.22%
02:05PM	Top Midday Gainers (MT Newswires)
01:52PM	Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Heres Why. (Barrons.com)
12:08PM	Update: Bio-Techne Shares Jump After Fiscal Q3 Beat (MT Newswires)
11:10AM	Deutsche Bank Adjusts Price Target on Bio-Techne to $84 From $82 (MT Newswires)
09:30AM	Techne (TECH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:36AM	Bio-Techne's Fiscal Q3 Adjusted Earnings Fall, Net Sales Rise (MT Newswires)
07:51AM	Bio-Techne Corp (TECH) Q3 Fiscal 2024 Earnings: Mixed Results Amid Market Challenges (GuruFocus.com)
07:40AM	Techne (TECH) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:29AM	Bio-Techne beats third-quarter estimates on improving demand for biotech products (Reuters)
06:30AM	BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Apr-30-24 07:00AM	BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS (PR Newswire)
Apr-29-24 10:38AM	Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific (MT Newswires)
09:39AM	RBC Capital Adjusts Price Target on Bio-Techne to $71 From $79 (MT Newswires)
07:00AM	BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC (PR Newswire)
Apr-26-24 07:00AM	BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY (PR Newswire)
Apr-24-24 10:01AM	Analysts Estimate Techne (TECH) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-23-24 07:00AM	BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS (PR Newswire)
Apr-10-24 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS (PR Newswire)
Apr-08-24 07:00AM	BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY (PR Newswire)
Apr-03-24 07:00AM	BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE (PR Newswire)
Apr-01-24 07:00AM	BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS (PR Newswire)
Mar-28-24 09:00AM	BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES (PR Newswire)
08:39AM	3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition (InvestorPlace)
Mar-22-24 07:00AM	BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA (PR Newswire)
Mar-18-24 08:01PM	7 Biotech Stocks Ready to Ride the Sectors Resurgence (InvestorPlace)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-12-24 07:00AM	BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM (PR Newswire)
Mar-11-24 07:00PM	Director Roeland Nusse Sells 10,400 Shares of Bio-Techne Corp (TECH) (GuruFocus.com)
Mar-06-24 07:00AM	BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
Feb-23-24 06:15AM	What Makes Bio-Techne Corporation (TECH) an Investment Bet? (Insider Monkey)
Feb-13-24 08:00AM	The 3 Best Biotech Stocks to Buy in February 2024 (InvestorPlace)
Feb-02-24 10:47AM	Bio-Techne Corporation (NASDAQ:TECH) Q2 2024 Earnings Call Transcript (Insider Monkey)
04:45AM	Q2 2024 Bio-Techne Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-01-24 12:57PM	Bio-Techne Corp (TECH) Reports Mixed Q2 Fiscal 2024 Results Amid Industry Headwinds (GuruFocus.com)
07:51AM	Bio-Techne misses quarterly estimates on persistently weak demand in China (Reuters)
07:07AM	Bio-Techne Q2 Results Miss Estimates; Declares Dividend (RTT News)
06:30AM	BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Jan-29-24 07:00AM	BIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW STANDARD IN SPATIAL BIOLOGY WITH PROTEASE-FREE RNASCOPE MULTIOMICS (PR Newswire)
Jan-25-24 07:00AM	LUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH WITH THE LAUNCH OF THE FIRST FULLY AUTOMATED, SAME-SECTION, HYPERPLEX MULTIOMICS APPLICATION (PR Newswire)
Jan-24-24 07:00AM	SCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN PROTEIN BIOTHERAPEUTIC CHARGE HETEROGENEITY CHARACTERIZATION USING THE MauriceFlex SYSTEM (PR Newswire)
Jan-21-24 01:16PM	3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024 (InvestorPlace)
Jan-16-24 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS (PR Newswire)
Jan-05-24 07:00AM	BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT (PR Newswire)
Jan-04-24 07:00AM	BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024 (PR Newswire)
Dec-21-23 07:00AM	BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Dec-20-23 07:00AM	BIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR EXCELLERATE GMP IPSC EXPANSION MEDIUM SUPPORTING STEM CELL THERAPY (PR Newswire)
Dec-14-23 07:00AM	LUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP INNOVATIVE AI-BASED ASSAY DEVELOPMENT TOOLS (PR Newswire)
Dec-01-23 01:32AM	Should You Hold Bio-Techne Corporation (TECH) For the Long Term? (Insider Monkey)
Nov-27-23 07:00AM	BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE (PR Newswire)
Nov-13-23 07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES (PR Newswire)
Nov-02-23 07:00AM	ASURAGEN TO PRESENT NOVEL CLINICAL TESTING DATA AT AMP 2023 CONFERENCE (PR Newswire)
Nov-01-23 10:44AM	Bio-Techne Corporation (NASDAQ:TECH) Q1 2024 Earnings Call Transcript (Insider Monkey)
Oct-31-23 07:53AM	Bio-Techne Corp (TECH) Reports 2% Organic Revenue Growth in Q1 FY2024 (GuruFocus.com)
07:27AM	Bio-Techne's quarterly profit misses estimates as biotech funding woes persist (Reuters)
06:30AM	BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Oct-25-23 03:42PM	3 AI Stock-Split Stocks to Buy Now (InvestorPlace)
09:00AM	LEADING RESEARCH INSTITUTES TO PRESENT NEW DATA USING LUNAPHORE'S COMET TECHNOLOGY AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 38th ANNUAL MEETING (PR Newswire)
Oct-22-23 10:30AM	Bearish Bets: 3 Stocks You Definitely Should Think About Shorting This Week (TheStreet.com)
Oct-20-23 05:01AM	Various Headwinds Pressured Bio-Techne Corporation (TECH) Shares in Q3 (Insider Monkey)
Oct-19-23 07:00AM	BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER (PR Newswire)
Oct-16-23 07:00AM	BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY (PR Newswire)
Oct-10-23 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS (PR Newswire)
Oct-03-23 09:45AM	3 Healthcare Stocks to Keep an Eye On (Motley Fool)

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kelderman Kim	Chief Executive Officer	Aug 29 '24	Option Exercise	66.97	1,492	99,919	41,434	Sep 03 04:05 PM
Bohnen Shane	SVP - General Counsel	Aug 15 '24	Option Exercise	0.00	49	0	1,696	Aug 19 05:28 PM
BAUMGARTNER ROBERT V	Director	Aug 08 '24	Option Exercise	22.95	16,000	367,200	59,401	Aug 12 04:08 PM
BAUMGARTNER ROBERT V	Director	Aug 08 '24	Sale	72.10	16,000	1,153,664	43,401	Aug 12 04:08 PM
ROBERT V. BAUMGARTNER	Director	Aug 08 '24	Proposed Sale	72.10	16,000	1,153,664		Aug 08 04:13 PM
Hippel James	CFO	Aug 02 '24	Option Exercise	31.26	53,000	1,656,780	136,002	Aug 06 04:23 PM
Kelderman Kim	Chief Executive Officer	Jul 31 '24	Option Exercise	37.70	14,000	527,800	49,421	Aug 02 04:17 PM
Hippel James	CFO	Jul 23 '24	Option Exercise	31.26	35,000	1,094,100	107,284	Jul 25 04:31 PM
HIGGINS JOHN L	Director	Jul 08 '24	Option Exercise	22.95	6,000	137,700	42,608	Jul 10 04:35 PM
HIGGINS JOHN L	Director	May 14 '24	Option Exercise	22.95	4,000	91,800	40,608	May 16 04:17 PM
HIGGINS JOHN L	Director	May 14 '24	Sale	83.84	4,000	335,377	36,608	May 16 04:17 PM
Nusse Roeland	Director	Mar 07 '24	Sale	76.98	10,400	800,627	43,097	Mar 11 04:04 PM
Hippel James	CFO	Dec 19 '23	Option Exercise	31.26	47,289	1,478,254	104,850	Dec 21 04:06 PM

QSI

Quantum-Si Incorporated

TECH

Bio-Techne Corp

Upgrade your FINVIZ experience